Cancel anytime
CareCloud Inc. (CCLD)CCLD
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/16/2024: CCLD (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -75.42% | Upturn Advisory Performance 1 | Avg. Invested days: 21 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 08/16/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -75.42% | Avg. Invested days: 21 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 08/16/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 44.26M USD |
Price to earnings Ratio - | 1Y Target Price 5.17 |
Dividends yield (FY) - | Basic EPS (TTM) -3.7 |
Volume (30-day avg) 64986 | Beta 1.35 |
52 Weeks Range 0.68 - 3.80 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 44.26M USD | Price to earnings Ratio - | 1Y Target Price 5.17 |
Dividends yield (FY) - | Basic EPS (TTM) -3.7 | Volume (30-day avg) 64986 | Beta 1.35 |
52 Weeks Range 0.68 - 3.80 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -40.28% | Operating Margin (TTM) 8.5% |
Management Effectiveness
Return on Assets (TTM) -0.06% | Return on Equity (TTM) -65.82% |
Valuation
Trailing PE - | Forward PE 3 |
Enterprise Value 50475147 | Price to Sales(TTM) 0.4 |
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA -0.99 |
Shares Outstanding 16213600 | Shares Floating 8498200 |
Percent Insiders 47.32 | Percent Institutions 10.6 |
Trailing PE - | Forward PE 3 | Enterprise Value 50475147 | Price to Sales(TTM) 0.4 |
Enterprise Value to Revenue 0.45 | Enterprise Value to EBITDA -0.99 | Shares Outstanding 16213600 | Shares Floating 8498200 |
Percent Insiders 47.32 | Percent Institutions 10.6 |
Analyst Ratings
Rating 4.5 | Target Price 4.98 | Buy 2 |
Strong Buy 2 | Hold - | Sell - |
Strong Sell - |
Rating 4.5 | Target Price 4.98 | Buy 2 | Strong Buy 2 |
Hold - | Sell - | Strong Sell - |
AI Summarization
CareCloud Inc. Stock Overview:
Please note that this information is based on publicly available data as of November 2023. It is important to conduct your own research and due diligence before making any investment decisions.
Company Profile:
Detailed history and background of CareCloud Inc.:
CareCloud Inc. was founded in 2009 as a cloud-based healthcare software provider. The company initially focused on offering Electronic Health Records (EHR) and Practice Management (PM) solutions to small and medium-sized medical practices. Over time, CareCloud expanded its product portfolio to include revenue cycle management (RCM) and patient engagement tools. In 2014, the company went public through an Initial Public Offering (IPO).
Description of the company’s core business areas:
- Cloud-based EHR and PM: CareCloud's core offering is its cloud-based EHR and PM software, designed to streamline administrative tasks and improve patient care for medical practices.
- Revenue Cycle Management (RCM): CareCloud offers RCM solutions to help medical practices manage their billing and claims processes.
- Patient Engagement: The company provides patient engagement tools that enable medical practices to communicate with their patients and improve patient satisfaction.
Overview of the company’s leadership team and corporate structure:
- Leadership:
- CEO: Albert Santalo
- CFO: William Davis
- CTO: Michael Battles
- Corporate Structure: CareCloud operates as a single business segment with headquarters in Miami, Florida.
Top Products and Market Share:
Identification and description of CareCloud Inc.'s top products and offerings:
- CareCloud Charts: Cloud-based EHR solution that manages patient records, scheduling, and billing.
- CareCloud RCM: Revenue cycle management solution that automates billing and claims processing.
- CareCloud Patient Engagement: Patient portal and messaging tools to improve communication and engagement.
Analysis of the market share of these products in the global and US markets:
- EHR Market: CareCloud holds a small market share in the global EHR market, estimated to be around 1%. The global EHR market is dominated by larger players like Cerner, Epic, and Allscripts.
- RCM Market: CareCloud has a larger market share in the RCM market, estimated to be around 5% in the US. The RCM market is also fragmented, with several competitors vying for market share.
- Patient Engagement Market: The patient engagement market is still evolving, and CareCloud's market share is difficult to estimate.
Comparison of product performance and market reception against competitors:
CareCloud's products have received mixed reviews from users. Some users praise the software's ease of use and functionality, while others have reported issues with customer support and software bugs.
CareCloud faces stiff competition from larger and more established players in the healthcare IT market. The company needs to differentiate its products and services to gain market share.
Total Addressable Market:
The global healthcare IT market is estimated to be worth over $150 billion. The US healthcare IT market is the largest, valued at approximately $50 billion.
CareCloud's total addressable market is significant, but the company faces intense competition.
Financial Performance:
Financial Performance Analysis:
CareCloud's financial performance has been mixed in recent years. The company has reported revenue growth, but it has also struggled with profitability. In 2022, CareCloud reported revenue of $120 million and a net loss of $10 million.
Year-over-year financial performance comparison:
CareCloud's revenue has grown in recent years, but its net income has fluctuated. The company needs to improve its profitability to attract investors.
Cash flow statements and balance sheet health:
CareCloud has a relatively weak balance sheet with limited cash reserves. The company needs to improve its cash flow and financial health to support its growth plans.
Dividends and Shareholder Returns:
Dividend History:
CareCloud does not currently pay dividends.
Shareholder Returns:
CareCloud's stock price has been volatile in recent years. The company's total shareholder returns have been negative over the past year.
Growth Trajectory:
Historical growth analysis:
CareCloud's revenue has grown at a compound annual growth rate (CAGR) of 15% over the past five years.
Future growth projections:
Analysts expect CareCloud's revenue to continue growing in the coming years. However, the company's profitability remains a concern.
Recent product launches and strategic initiatives on growth prospects:
CareCloud has recently launched new products and services aimed at expanding its market share. The company is also focusing on improving its profitability and cash flow.
Market Dynamics:
Industry overview:
The healthcare IT industry is growing rapidly, driven by factors such as the aging population, increasing healthcare costs, and the adoption of electronic health records.
Market trends:
Some key trends in the healthcare IT industry include the adoption of cloud-based solutions, the use of artificial intelligence (AI), and the focus on patient engagement.
CareCloud's positioning:
CareCloud is well-positioned to benefit from these trends, as its products and services are cloud-based and leverage AI. However, the company needs to execute effectively to capitalize on these opportunities.
Competitors:
Key competitors:
CareCloud's key competitors include Cerner (CERN), Epic (EPIC), Allscripts (MDRX), Athenahealth (ATHN), and Greenway Health (GWAY).
Market share of key competitors:
- Cerner: 25%
- Epic: 20%
- Allscripts: 15%
- Athenahealth: 10%
- Greenway Health: 5%
- CareCloud: 1%
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition
- Profitability concerns
- Weak balance sheet
- Customer support issues
Potential Opportunities:
- Growing healthcare IT market
- Adoption of cloud-based solutions
- Use of AI in healthcare
- Focus on patient engagement
Recent Acquisitions:
CareCloud has not made any acquisitions in the last three years.
AI-Based Fundamental Rating:
Rating: 7/10
Justification:
CareCloud has a solid product portfolio and is well-positioned to benefit from several industry trends. However, the company faces stiff competition and needs to improve its profitability.
Sources and Disclaimers:
The information in this report was gathered from the following sources:
- CareCloud Inc. website
- Securities and Exchange Commission (SEC) filings
- Industry reports
- News articles
This report is for informational purposes only and should not be considered investment advice. Please conduct your own research before making any investment decisions.
Disclaimer:
This report is based on publicly available information as of November 2023. The information may have changed since that time. Please conduct your own research before making any investment decisions.
Please note that the AI-based fundamental rating is just one factor to consider when evaluating a company's stock. You should also consider other factors, such as the company's financial performance, competitive positioning, and management team.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CareCloud Inc.
Exchange | NASDAQ | Headquaters | Somerset, NJ, United States |
IPO Launch date | 2014-07-23 | CEO & Director | Mr. A. Hadi Chaudhry |
Sector | Healthcare | Website | https://www.carecloud.com |
Industry | Health Information Services | Full time employees | 3600 |
Headquaters | Somerset, NJ, United States | ||
CEO & Director | Mr. A. Hadi Chaudhry | ||
Website | https://www.carecloud.com | ||
Website | https://www.carecloud.com | ||
Full time employees | 3600 |
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.